Use of the Hazard Analysis and Critical Control Points (HACCP) risk assessment on a medical device for parenteral application

PDA Journal of Pharmaceutical Science and Technology

Volumn 57, Issue 1, 2003, Pages 32-42

  Jahnke, Michael ^a   Kühn, Klaus Dieter ^b  

^a Wulfing Pharma GmbH   (Germany)

^b KG   (Germany)

Author keywords

[No Author keywords available]

Indexed keywords

BENZOYL PEROXIDE; BONE CEMENT; CHLOROPHYLL; HYDROQUINONE; METHACRYLIC ACID METHYL ESTER; N,N DIMETHYL 4 TOLUIDINE; PALACOS; PARENTERAL SOLUTION; TOLUIDINE DERIVATIVE; UNCLASSIFIED DRUG; ZIRCONIUM OXIDE;

AMPOULE; ARTICLE; DEVICE; DRUG DELIVERY SYSTEM; DRUG INDUSTRY; DRUG MANUFACTURE; GOOD MANUFACTURING PRACTICE; HAZARD ASSESSMENT; HYGIENE; PROCESS CONTROL; QUALITY CONTROL; RISK ASSESSMENT;

BONE CEMENTS; HUMANS; METHYLMETHACRYLATE; SAFETY MANAGEMENT; TECHNOLOGY, PHARMACEUTICAL;

EID: 0037286138     PISSN: 10797440     EISSN: None     Source Type: Journal    
DOI: None     Document Type: Article

References (40)

1. Ege, W. (1993), "Knochenzement," in Planck, H., Kunststoffe und Elastomere in der Medizin., Kohlhammer GmbH, Stuttgart, 112-121.
2. Kühn, K.-D. (2001), "Knochenzemente för die Endoprothetik," Ein aktueller Vergleich der physikalischen und chemischen Eigenschaften handelsüblicher PMMA-Zemente, Springer Verlag Heidelberg.
3. Kühn, K.-D., Specht, R., Ege, W. et al. (2001), "Mechanical Properties of Bone Cements," in Bone Cement and Cementin"g Techniques, G.H.I.M. Walenkamp and D.W. Murray (eds), Springer Verlag Heidelberg, 27-42.
4. Auterhoff, G., (2000), "EC Guide to Good Manufacturing Practices for Medicinal Products," 3. Aufl., Editio Cantor Verlag, Aulendorf.
5. EN 1441, Medical Devices - Risk Analysis, 1997.
6. ISO 14971, Medical Devices - Application of risk management to medical devices, 2000.
7. IEC 60812, Analysis techniques for system reliability - Procedure for failure mode and effects analysis (FMEA), 1985.
8. FDA, Federal Register Part VII: 21 CFR Part 808, 812, 820, Medical Devices, cGMP, Final Rule, 1996.
9. Pierson, M. D. (edt.), HACCP. Grundlagen der produkt- und prozessspezifischen Risikoanalyse, Behr's Verlag Hamburg, 1993.
10. World Health Organization, (May 1995a), "Hazard analysis critical control point system, concept and application," Report of a WHO consultation with the participation of FAO, WHO/FNU/FOS/95.7.
11. World Health Organization, (June 1995b), "Training aspects of the hazard analysis critical control point system (HACCP)," Report of a WHO workshop on training in HACCP with the participation of FAO. Geneva, WHO/FNU/FOS/96.3.
12. Cullor, J. S. (1996), "An HACCP learning module for graduate veterinarians," J. Amer. Vet. Med. Assoc., 209 (12), 2049-2050.
13. Jahnke, M., (1997), "Use of the HACCP concept for the risk analysis of pharmaceutical manufacturing processes," European Journal of Parenteral Sciences, 2 (4), 113-117.
14. Jahnke, M., (2000), "Hazard Analysis and Critical Control Points in a Pharmaceutical QA System," in Pharmaceutical Quality Systems, Schmidt, O. (ed), Interpharm Press, Englewood, USA, 319-361.
15. Seyfarth, H., (1997), "Mikrobiologische Gesichtspunkte bei der Arzneimittelherstellung," Swiss Pharma, 19 (11), 17-35.
16. Anonymous, (1991), "The principles and guidelines of good manufacturing practice for medicinal products for human use," Commission Directive 91/356/EEC.
17. Anonymous, (1998 a), "Current good manufacturing practice in manufacturing, processing, packing or holding of drugs/current good manufacturing practice for finished products," Code of Federal Regulations 21 CFR, Parts 210/211.
18. USP, (2000a), "Good manufacturing practices for bulk pharmaceutical excipients," The United States Pharmacopeia 24, NF 19 〈1078〉, 2040-2049.
19. Wang, Y. and Chien, Y. W., (1984), "Technical Report No. 5, Sterile Pharmaceutical Packaging: Compatibility and Stability," Parenteral Drug Association, Inc., Philadelphia, USA.
20. Lorenzen, K., Pracht, T., and Jahnke, M., (1999), "Effects of temperature stress on the glass quality of ampoules for parenteral drug production," European Journal of Parenteral Sciences, 5 (1), 13-19.
21. USP, (2000 b), "Antimicrobial Effectiveness Test," The United States Pharmacopeia 24, NF 19 〈51〉 1809-1811.
22. USP, (2000 c), "Microbial Limit Test," The United States Pharmacopeia 24, NF 19 〈61〉 1814-1818.
23. ICH, (1994), Guide for Industry: Stability testing of New Drug Substances and Products.
24. EMEA, (1999), Note for Guidance on In-use Stability Testing of Human Medicinal Products.
25. Docksey, S., Cappia, J.-M., and Rabine, D. (1999), "A general approach to the validation of sterilizing filtration used in aseptic processing," European Journal of Parenteral Sciences, 4 (3), 95-101.
26. The Parenteral Society, (1999), "Steam Sterilization Validation, Technical Monograph No. 11," Swindon, UK.
27. USP, (2000 d), "Microbiological Evaluation of Clean Rooms and Other Controlled Environments," The United States Pharmacopeia 24, NF 19 〈1116〉 2099-2106.
28. Jahnke, M. (2001), Introduction to the Environmental Monitoring of Pharmaceutical Areas, Davis Horwood International Publishing Ltd., Raleigh, NC, USA.
29. Jahnke, M. (2001), Aseptic Processing: The Importance of Microbiology and Environmental Monitoring in Media Fill Validation, Davis Horwood International Publishing Ltd., Raleigh, NC, USA.
30. PDA, (1996), "Technical Report No. 24, Current Practices in the Validation of Aseptic Processing," Parenteral Drug Association.
31. Cope, M. (2000), "Analytical method validation," European Journal of Parenteral Sciences, 5 (4), 93-96.
32. USP, (2000 e), "Sterility Tests," The United States Pharmacopeia 24, NF 19 〈71〉 1818-1823.
33. FDA, (July 1993), Guide to Inspection of Validation of Cleaning Processes.
34. PDA, (1998), "Technical Report No. 29, Points to Consider for Cleaning Validation," Parenteral Drug Association.
35. Bogatz, C. and Merdian, J. (1997), "HACCP und Qualitätsmanagement - perfekte Systemsynergien," Journal for the Food Industry, 48 (5), 30-33.
36. Kohlert, E. U. and Kohrt,A. (1998), "Pharmaceutical quality assurance, production and quality control as columns of a quality management system," Pharmaceutische Industrie, 60 (3), 200-204.
37. Leaper, S. (ed), (1992), "Technical Manual No. 38, HACCP: A Practical Guide," Campden Food and Drink Research Association.
38. Mitchell, R. T. (1992), "How to HACCP," British Food Journal, 94 (1), 16-20.
39. Mortimore, S. and Wallace, C. (1994), HACCP: A Practical Approach, Chapmann and Hall, London.
40. ISO 5833, (1996), Implants for Surgery - Acrylic Resin Cements.